The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Explaining the Decline in Coronary Heart Disease Mortality in Finland between 1982 and 1997
Abstract
In Finland since the 1980s, coronary heart disease mortality has declined more than might be predicted by risk factor reductions alone. The aim of this study was to assess how much of the decline could be attributed to improved treatments and risk factor reductions. The authors used the cell-based IMPACT mortality model to synthesize effectiveness of treatments and risk factor reductions with data on treatments administered to patients and trends in cardiovascular risk factors in the population. Cardiovascular risk factors were measured in random samples of patients in 1982 (n=8,501) and 1997 (n=4,500). Mortality and treatment data were obtained from the National Causes of Death Register, Hospital Discharge Register, social insurance data, and medical records. Estimated and observed changes in coronary heart disease mortality were used as main outcome measures. Between 1982 and 1997, coronary heart disease mortality rates declined by 63%, with 373 fewer deaths in 1997 than expected from baseline mortality rates in 1982. Improved treatments explained approximately 23% of the mortality reduction, and risk factors explained some 53-72% of the reduction. These findings highlight the value of a comprehensive strategy that promotes primary prevention programs and actively supports secondary prevention. It also emphasizes the importance of maximizing population coverage of effective treatments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
OLSSON, A. G., McMurray, J. J. V., Thorgeirsson, G., Spaulding, C. M., Slattery, J., Pyörälà, K., Færgeman, O., Wright, R. S., Berg, K. M., Wilhelmsen, L., et al. (1994) · The Lancet · Cited by 8,467
The World Health Report 2002 - Reducing Risks, Promoting Healthy Life
Not Available, N. A. (2003) · Education for Health: Change in Learning & Practice · doi:10.1080/1357628031000116808 · Cited by 6,046
Blood pressure, stroke, and coronary heart disease
Collins, R., Peto, R., MacMahon, S., Godwin, J., Qizilbash, N., Collins, R., MacMahon, S., Hebert, P., Eberlein, K. A., Taylor, J. O., et al. (1990) · The Lancet · doi:10.1016/0140-6736(90)90944-z · Cited by 4,491
SCANDINAVIANSIMVASTATINSURVIVAL (1994) · The Lancet · doi:10.1016/s0140-6736(94)90566-5 · Cited by 3,645
Altman, R., Carreras, L., Díaz, R. S., Figueroa, E. B., Paolasso, E., Parodi, J. C., Cade, J. F., Donnan, G. A., Eadie, M. J., Gavaghan, T. P., et al. (1994) · Cited by 3,322
Antiplatelet Trialists' Collaboration (1994) · BMJ · doi:10.1136/bmj.308.6921.81 · Cited by 3,126
PEDERSEN, T. R. (2004) · Atherosclerosis Supplements · doi:10.1016/j.atherosclerosissup.2004.08.027 · Cited by 3,106
Fibrinolytic Therapy Trialists' (FTT) Collaborative Group (1994) · The Lancet · doi:10.1016/s0140-6736(94)91161-4 · Cited by 2,744
Garg, R. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03520420066040 · Cited by 1,771
Law, M. R., Wald, N. J., & Thompson, S. G. (1994) · BMJ · doi:10.1136/bmj.308.6925.367 · Cited by 1,210
Critchley, J. A., & Capewell, S. (2003) · JAMA · doi:10.1001/jama.290.1.86 · Cited by 1,089
Self-citationKuulasmaa, K., Tunstall-Pedoe, H., Dobson, A., Fortmann, S., Sans, S., Tolonen, H., Evans, A., & Ferrario, M. (2000) · The Lancet · doi:10.1016/s0140-6736(99)11180-2 · Cited by 952
Unal, B., Critchley, J. A., & Capewell, S. (2004) · Circulation · doi:10.1161/01.cir.0000118498.35499.b2 · Cited by 739
Self-citationHunink, M. G. M. (1997) · JAMA · doi:10.1001/jama.277.7.535 · Cited by 679
Aromaa, A. J., & Koskinen, S. V. P. (2004) · Cited by 583
Uncertainty in the economic evaluation of health care technologies: the role of sensitivity analysis
Briggs, A., Sculpher, M., & Buxton, M. (1994) · Health Economics · doi:10.1002/hec.4730030206 · Cited by 521
Kendall's Advanced Theory of Statistics, Volume 1: Distribution Theory.
Zacks, S., Stuart, A., & Ord, J. K. (1989) · Journal of the American Statistical Association · doi:10.2307/2289685 · Cited by 515
Changes in risk factors explain changes in mortality from ischaemic heart disease in Finland
Vartiainen, E., Puska, P., Pekkanen, J., Toumilehto, J., & Jousilahti, P. (1994) · BMJ · doi:10.1136/bmj.309.6946.23 · Cited by 438
Self-citationCardiovascular risk factor changes in Finland, 1972–1997
Vartiainen, E., Jousilahti, P., Alfthan, G., Sundvall, J., Pietinen, P., & Puska, P. (2000) · International Journal of Epidemiology · doi:10.1093/ije/29.1.49 · Cited by 401
Self-citationGOLDMAN, L., & COOK, E. F. (1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-101-6-825 · Cited by 381
Capewell, S., Morrison, C. E., & McMurray, J. J. (1999) · Heart · doi:10.1136/hrt.81.4.380 · Cited by 308
Self-citationExplaining the Increase in Coronary Heart Disease Mortality in Beijing Between 1984 and 1999
Critchley, J., Liu, J., Zhao, D., Wei, W., & Capewell, S. (2004) · Circulation · doi:10.1161/01.cir.0000140668.91896.ae · Cited by 304
Self-citationMant, J., & Hicks, N. (1995) · BMJ · doi:10.1136/bmj.311.7008.793 · Cited by 303
Capewell, S., Beaglehole, R., Seddon, M., & McMurray, J. (2000) · Circulation · doi:10.1161/01.cir.102.13.1511 · Cited by 253
Self-citationACE Inhibitor Use in Patients With Myocardial Infarction: Summary of Evidence From Clinical Trials
Latini, R., Maggioni, A. P., Flather, M., Sleight, P., & Tognoni, G. (1995) · Circulation · doi:10.1161/01.cir.92.10.3132 · Cited by 247
Smoking and hypertension as predictors of cardiovascular risk in population studies.
Kannel, W. B., & HIGGINS, M. W. (1990) · PubMed · Cited by 164
Emberson, J., Whincup, P. H., Morris, R. W., & Walker, M. (2003) · European Heart Journal · doi:10.1016/s0195-668x(03)00471-8 · Cited by 139
A Critical Evaluation of the Methodology of the Literature on Medication Compliance
Nichol, M. B., Venturini, F., & Sung, J. (1999) · Annals of Pharmacotherapy · doi:10.1345/aph.18233 · Cited by 114
Stamler, J., Wentworth, D. N., & Neaton, J. D. (1986) · The American Journal of Medicine · doi:10.1016/0002-9343(86)90158-0 · Cited by 113
Decline in ischaemic heart disease in Iceland and change in risk factor levels.
Sigfússon, N., Sigvaldason, H., Steingrímsdóttir, L., Gudmundsdottir, I. I., Stefansdottir, I., Thorsteinsson, T., & Sigurðsson, G. (1991) · BMJ · doi:10.1136/bmj.302.6789.1371 · Cited by 103
Salomaa, V. V., Miettinen, H., Kuulasmaa, K., Niemela, M. R., Ketonen, M., Vuorenmaa, T., Lehto, S., Paloma¨ki, P., nen, M. M. H., Immonen‐Räihä, P., et al. (1996) · Circulation · doi:10.1161/01.cir.94.12.3130 · Cited by 97
Self-citationMedical management and the decline in mortality from coronary heart disease.
Beaglehole, R. (1986) · BMJ · doi:10.1136/bmj.292.6512.33 · Cited by 94
Twenty-five-year trends in physical activity of 30- to 59-year-old populations in eastern Finland
Barengo, N. C., Nissinen, A. M., Tuomilehto, J., & Pekkarinen, H. (2002) · Medicine & Science in Sports & Exercise · doi:10.1097/00005768-200208000-00011 · Cited by 89
Determinants of energy balance and overweight in Finland 1982 and 1992.
Fogelholm, M., Männistö, S., Vartiainen, E. A., & Pietinen, P. (1996) · PubMed · Cited by 89
Self-citationTrends in coronary events in Finland during 1983–1997; The FINAMI study
Salomaa, V. V. (2003) · European Heart Journal · doi:10.1016/s0195-668x(02)00421-9 · Cited by 76
Self-citationBots, M. L., & Grobbee, D. E. (1996) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1177/174182679600300302 · Cited by 76
Salomaa, V. V., Ketonen, M., Koukkunen, H., Immonen‐Räihä, P., Jerkkola, T., Kärjä-Koskenkari, P., Mähönen, M., Niemelä, M., Kuulasmaa, K., Palomäki, P., et al. (2003) · Circulation · doi:10.1161/01.cir.0000083720.35869.ca · Cited by 66
Self-citationBots, M. L., & Grobbee, D. E. (1996) · Journal of Cardiovascular Risk · doi:10.1097/00043798-199606000-00002 · Cited by 55
Regression analysis of recent changes in cardiovascular morbidity and mortality in the netherlands
Bonneux, L. G. A., Looman, C. W. N., Barendregt, J. J., & van der Maas, P. J. (1997) · BMJ · doi:10.1136/bmj.314.7083.789 · Cited by 54
The Development of a Simulation Model of the Treatment of Coronary Heart Disease
Cooper, K., Davies, R., Roderick, P., Chase, D., & Raftery, J. (2002) · Health Care Management Science · doi:10.1023/a:1020378022303 · Cited by 53
McAlister, F. A. (2002) · International Journal of Epidemiology · doi:10.1093/ije/31.1.76 · Cited by 52
Why model coronary heart disease?
Critchley, J. (2002) · European Heart Journal · doi:10.1053/euhj.2001.2681 · Cited by 45
Self-citationIncreasing the impact of cardiological treatments. How best to reduce deaths
Capewell, S., Pell, J. P., Morrison, C., & McMurray, J. (1999) · European Heart Journal · doi:10.1053/euhj.1999.1631 · Cited by 40
Self-citationCritchley, J., & Capewell, S. (2003) · Journal of Epidemiology & Community Health · doi:10.1136/jech.57.4.243 · Cited by 36
Self-citationEffects of cigarette smoking and propranolol in survivors of acute myocardial infarction
Jafri, S. M., Tilley, B. C., Peters, R. W., et al. (1990) · The American Journal of Cardiology · doi:10.1016/0002-9149(90)90286-a · Cited by 34
Missing, mediocre, or merely obsolete? An evaluation of UK data sources for coronary heart disease
Ünal, B., Critchley, J., & Capewell, S. (2003) · Journal of Epidemiology & Community Health · doi:10.1136/jech.57.7.530 · Cited by 32
Self-citationDoliszny, K. M., Luepker, R. V., Burke, G. L., Pryor, D. B., & Blackburn, H. (1994) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)90547-9 · Cited by 29
Development of public policy on the prevention and control of elevated blood cholesterol
Puska, P. (1996) · STM:n Hallinnonalan avoin julkaisuarkisto (Julkari) · Cited by 14
Cited by
Forouzanfar, M. H., Afshin, A., Alexander, L. T., Anderson, H. R., Bhutta, Z. A., Biryukov, S., Brauer, M., Burnett, R., Cercy, K., Charlson, F. J., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31679-8 · Cited by 7,698
Lloyd-Jones, D. M., Hong, Y., Labarthe, D., Mozaffarian, D., Appel, L. J., Van Horn, L., Greenlund, K., Daniels, S., Nichol, G., Tomaselli, G. F., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.192703 · Cited by 4,750
Explaining the decrease in U.S. deaths from coronary disease, 1980–2000
Ford, E. S., Ajani, U. A., Croft, J. B., Critchley, J. A., Labarthe, D. R., Kottke, T. E., Giles, W. H., & Capewell, S. (2007) · New England Journal of Medicine · doi:10.1056/nejmsa053935 · Cited by 2,757
Self-citationForouzanfar, M. H., Alexander, L., Anderson, H. R., Bachman, V. F., Biryukov, S., Brauer, M., Burnett, R., Casey, D., Coates, M. M., Cohen, A., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00128-2 · Cited by 2,701
Cardiovascular Disease and Diabetes: Policies for Better Health and Quality of Care
OECD (2015) · OECD Health Policy Studies · doi:10.1787/9789264233010-en · Cited by 1,359
Metadata
- Authors
- Laatikainen, T., Critchley, J., Vartiainen, E., Salomaa, V., Ketonen, M., & Capewell, S.
- Venue
- American Journal of Epidemiology
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-09-08
- Volume
- 162
- Issue
- 8
- Pages
- 764-773
- ISSN
- 0002-9262 (ISSN-L)
- 1476-6256
- OpenAlex
- W2169631376
- Cited by
- 331
- References
- 48
- FWCI
- 12.87
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.